It's happening! New offer from Ackman. New horizons.

[Anonymous]

I wonder if Valeant's stock price can support this. They can't afford more cash.

 

[Anonymous]

I wonder if Valeant's stock price can support this. They can't afford more cash.

But they can afford more Valeant stock...

 

[Anonymous]

With $8.7 in 2015 EPS, the stock won't fall. It will stay where it is.

20 * $8.7 = $174.

Exactly why $200 a share is a great price. And if anything should go slightly wrong and if we don't hit these EPS 2015 and EPS 2016 numbers our stock will fall.

 

[Anonymous]

Exactly why $200 a share is a great price. And if anything should go slightly wrong and if we don't hit these EPS 2015 and EPS 2016 numbers our stock will fall.

No the price will triple to $900 a share after the smoking hot stock has received new legs tomorrow.

 

[Anonymous]

I agree with everything the poster above said except I don't think the stock goes all the way back to $120. I believe if the deal fell through it would fall to $140. Everything else is spot on.

90 100 120, who cares it's all bad, this deal will get inked this yr for sure now, I should have listened makes me sick to my stomach, that's for sure.

 

[Anonymous]

90 100 120, who cares it's all bad, this deal will get inked this yr for sure now, I should have listened makes me sick to my stomach, that's for sure.

You've been saying this for months intern

 

[Anonymous]

Quantitative Easing 3 is over as of today: Farewell, QE3! OK, now what is the strategery, Valeant? Your junk bonds are OK for 2 or 3 more years, but then what, as they mature and have to be rolled over into higher-interest junk loans? Would also like to know your future plan if the hostile takeover of Allergan goes nowhere, and you cannot rely on their juicy cash balance sheet and sterling bond rating to leverage your way out of your predicament.